Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

IMPORTANCE: Vaccination against the SARS-CoV-2 virus is critical to control the pandemic. Randomized clinical trials demonstrated efficacy of the single-dose Ad26.COV2.S COVID-19 vaccine, but data on longer-term protection in clinical practice and effectiveness against variants are needed. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Polinski, Jennifer M., Weckstein, Andrew R., Batech, Michael, Kabelac, Carly, Kamath, Tripthi, Harvey, Raymond, Jain, Sid, Rassen, Jeremy A., Khan, Najat, Schneeweiss, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931562/
https://www.ncbi.nlm.nih.gov/pubmed/35297969
http://dx.doi.org/10.1001/jamanetworkopen.2022.2959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931562/
https://www.ncbi.nlm.nih.gov/pubmed/35297969
http://dx.doi.org/10.1001/jamanetworkopen.2022.2959

Ejemplares similares